{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:20:29Z","timestamp":1792844429243,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013379","name":"Instituto Mente e C\u00e9rebro - Neuroci\u00eancia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006303","name":"Associa\u00e7\u00e3o Fundo de Incentivo \u00e0 Pesquisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006303","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Estado de Santa Catarina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013360","name":"Universidade do Extremo Sul Catarinense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Estado de Santa Catarina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.pbb.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T11:07:20Z","timestamp":1559300840000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Coadministration of lithium and celecoxib attenuates the behavioral alterations and inflammatory processes induced by amphetamine in an animal model of mania"],"prefix":"10.1016","volume":"183","author":[{"given":"Samira S.","family":"Valvassori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo C.","family":"Dal-Pont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula T.","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger B.","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila L.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda F.","family":"Gava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2019.05.009_bb0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10815-010-9426-3","article-title":"Lithium protects against toxic effects of cadmium in the rat testes","volume":"27","author":"Al-Azemi","year":"2010","journal-title":"J. Assisted Reprod. Genet."},{"key":"10.1016\/j.pbb.2019.05.009_bb0010","series-title":"Bipolar Disorder and Relationship","first-page":"123","article-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM5)","year":"2013"},{"key":"10.1016\/j.pbb.2019.05.009_bb0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bdi.12324","article-title":"Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial","volume":"17","author":"Arabzadeh","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pbb.2019.05.009_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360481","article-title":"Cytokines in bipolar disorder: paving the way for neuroprogression","volume":"2014","author":"Barbosa","year":"2014","journal-title":"Neural Plast"},{"key":"10.1016\/j.pbb.2019.05.009_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2004.11.009","article-title":"Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder","volume":"85","author":"Bauer","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pbb.2019.05.009_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpsychires.2014.04.017","article-title":"Inflammatory mediators of cognitive impairment in bipolar disorder","volume":"56","author":"Bauer","year":"2014","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.pbb.2019.05.009_bb0035","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00127-014-0887-z","article-title":"Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors","volume":"49","author":"Baumeister","year":"2014","journal-title":"Soc Psiquiatria Psychiatr Epidemiol"},{"issue":"2","key":"10.1016\/j.pbb.2019.05.009_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbr.2012.07.007","article-title":"Celecoxib delays cognitive decline in an animal model of neurodegeneration","volume":"234","author":"Borre","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.pbb.2019.05.009_bb0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrd1342","article-title":"Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention","author":"Braddock","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pbb.2019.05.009_bb0050","series-title":"Experiments in Personality. Am J Psychiatry","first-page":"31","article-title":"Experiments in psychogenetics","volume":"vol. 1","author":"Broadhurst","year":"1960"},{"issue":"3","key":"10.1016\/j.pbb.2019.05.009_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jnr.10192","article-title":"Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat","volume":"68","author":"Casolini","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.pbb.2019.05.009_bb7015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1741-4520.2006.00126.x","article-title":"Histological brain alterations following prenatal methamphetamine exposure in rats","volume":"46","author":"Cui","year":"2006","journal-title":"Congenit. Anom. (Kyoto)."},{"issue":"4","key":"10.1016\/j.pbb.2019.05.009_bb0060","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/CMR.10.4.742","article-title":"A primer on cytokines: sources, receptors, effects, and inducers","author":"Curfs","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.pbb.2019.05.009_bb0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biopha.2016.05.024","article-title":"Celecoxib and omega-3 fatty acids alone and in combination with risperidone affect the behavior and brain biochemistry in amphetamine-induced model of schizophrenia","volume":"82","author":"El-Sayed El-Sisi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pbb.2019.05.009_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neulet.2012.09.039","article-title":"Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine","volume":"530","author":"Feier","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.pbb.2019.05.009_bb0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1139\/jpn.0637","article-title":"Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania","volume":"31","author":"Frey","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pbb.2019.05.009_bb0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1399-5618.2006.00318.x","article-title":"Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania","volume":"8","author":"Frey","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pbb.2019.05.009_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pbb.2018.12.006","article-title":"Revisiting inflammation in bipolar disorder","volume":"177","author":"Fries","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2019.05.009_bb0095","doi-asserted-by":"crossref","first-page":"1672e82","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2019.05.009_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4088\/JCP.1006e12","article-title":"Cognitive impairment and functional outcome in schizophrenia and bipolar disorder","volume":"67","author":"Green","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2019.05.009_bb0105","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.neuint.2012.07.003","article-title":"GSK-3 mediates the release of IL-1\u03b2, TNF-\u03b1 and IL-10 from cortical glia","volume":"61","author":"Green","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pbb.2019.05.009_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.10.002","article-title":"Integrating the monoamine, neurotrophin and cytokine hypotheses of depression\u2014a central role for the serotonin transporter","volume":"147","author":"Haase","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.pbb.2019.05.009_bb0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12974-018-1283-5","article-title":"ITGB4 deficiency in bronchial epithelial cells directs airway inflammation and bipolar disorder-related behavior","volume":"15","author":"Han","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pbb.2019.05.009_bb0120","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jpsychires.2013.07.026","article-title":"Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro","volume":"47","author":"Himmerich","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pbb.2019.05.009_bb0125","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2265.2007.02963.x","article-title":"Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder","volume":"67","author":"Hung","year":"2007","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.pbb.2019.05.009_bb0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0165-0327(94)00094-P","article-title":"Urinary catecholamines and plasma hormones predict mood state in rapid cycling bipolar affective disorder","volume":"33","author":"Joyce","year":"1995","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.pbb.2019.05.009_bb0135","first-page":"45","article-title":"Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide","volume":"Apr 5","author":"Kaizaki","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"Pt A","key":"10.1016\/j.pbb.2019.05.009_bb0140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arr.2015.03.003","article-title":"DAMPs activating innate immune responses in sepsis","volume":"24","author":"Kang","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.pbb.2019.05.009_bb0145","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0025-7125(05)70334-5","article-title":"Bipolar disorder","volume":"85","author":"Keck","year":"2001","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1016\/j.pbb.2019.05.009_bb0150","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1523\/JNEUROSCI.19-04-01484.1999","article-title":"Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine","volume":"19","author":"LaVoie","year":"1999","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2019.05.009_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.12.049","article-title":"Can bipolar disorder be viewed as a multi-system inflammatory disease?","volume":"141","author":"Leboyer","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pbb.2019.05.009_bb0160","doi-asserted-by":"crossref","first-page":"424\u2212433","DOI":"10.1002\/jcp.22348","article-title":"Modulation of the development of human monocyte-derived dendritic cells by lithium chloride","volume":"226","author":"Liu","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.pbb.2019.05.009_bb0165","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/gps.4048","article-title":"The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder","volume":"29","author":"Lotrich","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2019.05.009_bb0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2019.05.009_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.02.003","article-title":"The role of immune cells, glia and neurons in withe and gray matter pathology in multiple sclerosis","volume":"127-128C","author":"Mallucci","year":"2015","journal-title":"Prog. Neurobiol."},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2019.05.009_bb0180","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/sj.mp.4001068","article-title":"Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics","volume":"7","author":"Manji","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2019.05.009_bb0185","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1124\/jpet.301.2.494","article-title":"Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity","volume":"301","author":"Mirjany","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pbb.2019.05.009_bb7000","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaac.2013.11.013","article-title":"Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review","volume":"53","author":"Mitchell","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2019.05.009_bb0190","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bdi.12214","article-title":"Immune dysfunction in bipolar disorder and suicide risk: is there an association between peripheral corticotropin-releasing hormone and interleukin-1\u03b2?","volume":"16","author":"Monfrim","year":"2014","journal-title":"Bipolar Disord."},{"issue":"6","key":"10.1016\/j.pbb.2019.05.009_bb0195","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1089\/cap.2016.0207","article-title":"A randomized, double-blind placebo-controlled trial on effectiveness and safety of celecoxib adjunctive therapy in adolescents with acute bipolar mania","volume":"27","author":"Mousavi","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pbb.2019.05.009_bb0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2014.09.021","article-title":"Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients","volume":"43","author":"Munkholm","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.pbb.2019.05.009_bb0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Nery","year":"2008","journal-title":"Hum Psychopharmacol"},{"issue":"10","key":"10.1016\/j.pbb.2019.05.009_bb0210","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders","volume":"13","author":"Nestler","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2019.05.009_bb0215","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pbb.2019.05.009_bb0220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","author":"O'Brien","year":"2006","journal-title":"J Affect Dis"},{"key":"10.1016\/j.pbb.2019.05.009_bb0225","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: phasic differences","volume":"9","author":"Ortiz-Dominguez","year":"2007","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.pbb.2019.05.009_bb0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1056-8719(97)83624-6","article-title":"TNF-alpha release from human peripheral blood mononuclear cells to predict the proinflammatory activity of cytokines and growth factors","volume":"37","author":"Oshiro","year":"1997","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"1","key":"10.1016\/j.pbb.2019.05.009_bb0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.psychres.2003.06.002","article-title":"Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in the Korean population","volume":"125","author":"Pae","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pbb.2019.05.009_bb0240","first-page":"95","article-title":"General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases","volume":"170C","author":"Perugi","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.pbb.2019.05.009_bb0245","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/npp.2011.45","article-title":"Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder","volume":"36","author":"Pinsonneault","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2019.05.009_bb0250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.pbb.2019.05.009_bb0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0006-3223(01)01144-1","article-title":"The effects of lithium on ex vivo cytokine production","volume":"50","author":"Rapaport","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2019.05.009_bb7010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-3956(99)00007-2","article-title":"Immune parameters in rapid cycling bipolar patients before and after lithium treatment","volume":"33","author":"Rapaport","year":"1999","journal-title":"J. Psychiatr. Res."},{"issue":"Feb 13","key":"10.1016\/j.pbb.2019.05.009_bb0260","article-title":"Targeting the immune system in the treatment of bipolar disorder","author":"Rosenblat","year":"2019","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2019.05.009_bb0265","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.psc.2015.09.006","article-title":"Bipolar disorder and inflammation","volume":"39","author":"Rosenblat","year":"2016","journal-title":"Psychiatr Clin North Am."},{"key":"10.1016\/j.pbb.2019.05.009_bb0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2019.05.009_bb0275","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(02)02104-0","article-title":"Cyclooxygenase inhibitor modulation of dopamine-related behaviours","volume":"450","author":"Ross","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.05.009_bb0280","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00228-007-0400-7","article-title":"Clinical use and pharmacological properties of selective COX-2 inhibitors","volume":"64","author":"Shi","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2019.05.009_bb0285","series-title":"Pharmacology of Pain","first-page":"279","article-title":"Cytokines, chemokines, and pain","author":"Sommer","year":"2010"},{"issue":"3","key":"10.1016\/j.pbb.2019.05.009_bb7005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/jpet.104.080242","article-title":"Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced neurotoxicity","volume":"313","author":"Thomas","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pbb.2019.05.009_bb0290","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1471-4159.2008.05421.x","article-title":"Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling","volume":"106","author":"Thomas","year":"2008","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.pbb.2019.05.009_bb0295","first-page":"106","article-title":"Focus on: neurotransmitter systems","volume":"34","author":"Valenzuela","year":"2011","journal-title":"Alcohol Res Health"},{"issue":"14","key":"10.1016\/j.pbb.2019.05.009_bb0300","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jpsychires.2010.02.009","article-title":"Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine","volume":"44","author":"Valvassori","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.pbb.2019.05.009_bb0305","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/bdi.12299","article-title":"Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine","volume":"17","author":"Valvassori","year":"2015","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.pbb.2019.05.009_bb0310","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bdi.12503","article-title":"Lithium ameliorates sleep deprivation-induced mania-like behavior, hypothalamic-pituitary-adrenal (HPA) axis alterations, oxidative stress and elevations of cytokine concentrations in the brain and serum of mice","volume":"19","author":"Valvassori","year":"2017","journal-title":"Bipolar Disord. Jun"},{"issue":"2","key":"10.1016\/j.pbb.2019.05.009_bb0315","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s12035-017-0384-y","article-title":"The effects of histone deacetylase inhibition on the levels of cerebral cytokines in an animal model of mania induced by dextroamphetamine","volume":"55","author":"Valvassori","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.pbb.2019.05.009_bb0320","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.psychres.2012.11.021","article-title":"Evaluation of acetylcholinesterase in an animal model of mania induced by D-amphetamine","volume":"209","author":"Varela","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pbb.2019.05.009_bb0325","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000080958","article-title":"Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients","volume":"50","author":"Vogel","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pbb.2019.05.009_bb0330","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuint.2013.07.003","article-title":"Inhibition of glycogen synthase kinase-3\u03b2 by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes","volume":"63","author":"Wang","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pbb.2019.05.009_bb0335","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2009.05141.x","article-title":"Amphetamine toxicities: classical and emerging mechanisms","volume":"1187","author":"Yamamoto","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pbb.2019.05.009_bb0340","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cellsig.2008.10.014","article-title":"Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity","volume":"21","author":"Yuskaitis","year":"2009","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.pbb.2019.05.009_bb0345","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3171\/2016.7.JNS152995","article-title":"Lithium posttreatment confers neuroprotection through glycogen synthase kinase-3\u03b2 inhibition in intracerebral hemorrhage rats","volume":"127","author":"Zheng","year":"2017","journal-title":"J. Neurosurg."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305719301042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305719301042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:34:35Z","timestamp":1758774875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305719301042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":72,"alternative-id":["S0091305719301042"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2019.05.009","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coadministration of lithium and celecoxib attenuates the behavioral alterations and inflammatory processes induced by amphetamine in an animal model of mania","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}